Ramesh Kumar
CIK 1580074 · Chief Executive Officer · last filed 2023-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.4K
Companies
4
Total Filings
31
Lifetime Open-Market Net
-$1.47M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OCGN | Director | 0 | $1.27 | $0 | -$228.2K | 12 | 2023-06-09 |
| Traws Pharma, Inc. (ONTXW) Delisted | Chief Executive Officer | 102,227 | $0.07 | $6.9K | $50.0K | 6 | 2018-07-30 |
| Traws Pharma, Inc. (ONTX.W) Delisted | President and CEO | 78,417 | — | — | $0 | 2 | 2016-09-01 |
| ONTX | President and CEO | 123 | $19.14 | $2.4K | -$1.30M | 10 | 2016-01-28 |
Recent Filings · Page 2 of 4
31 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-04-21 | OCGN | Mixed | — | -$36.1K | EDGAR |
| 2021-01-04 | OCGN | Grant (A) | — | $0 | EDGAR |
| 2020-01-03 | OCGN | Grant (A) | — | $0 | EDGAR |
| 2018-07-30 | Traws Pharma, Inc. (ONTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-02-27 | Traws Pharma, Inc. (ONTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-05 | Traws Pharma, Inc. (ONTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-04-28 | Traws Pharma, Inc. (ONTXW) Delisted | Buy (P) | +23,810 | $50.0K | EDGAR |
| 2017-01-19 | Traws Pharma, Inc. (ONTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-19 | Traws Pharma, Inc. (ONTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-09-01 | Traws Pharma, Inc. (ONTX.W) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.